The combination of pegylated interferon (PEG-IFN) and ribavirin (RIBA) in the treatment of chronic hepatitis C (HCV) infection: preliminary report of a single centre experience

G Kanagasabai; Mathis Heydtmann; K O'Donnell; R Harrison; David Mutimer

The combination of pegylated interferon (PEG-IFN) and ribavirin (RIBA) in the treatment of chronic hepatitis C (HCV) infection: preliminary report of a single centre experience

G Kanagasabai, Mathis Heydtmann, K O'Donnell, R Harrison, David Mutimer

Birmingham Medical School
Immunology and Immunotherapy

Research output: Contribution to conference (unpublished) › Abstract

Original language	English
Pages	A117-A118
Publication status	Published - 1 Jan 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{6888e553a74e4e98bf970ae1537b410e,

title = "The combination of pegylated interferon (PEG-IFN) and ribavirin (RIBA) in the treatment of chronic hepatitis C (HCV) infection: preliminary report of a single centre experience",

author = "G Kanagasabai and Mathis Heydtmann and K O'Donnell and R Harrison and David Mutimer",

year = "2002",

month = jan,

day = "1",

language = "English",

pages = "A117--A118",

}